why choose us

First received: February 24, 2025

Clinical Trial: Antiplatelets and Intramyocardial Hemorrhage in STEMI: Incidence and Outcomes

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: STEMI

Study Type: OBSERVATIONAL


Official Title: Antiplatelets and Hemorrhagic MI

Brief Summary: The MIRON-PLATELET study is a retrospective, observational multi-center analysis assessing the impact of different antiplatelet therapies on hemorrhagic myocardial infarction (HMI) incidence and outcomes in STEMI patients.Key endpoints include hemorrhagic transformation, MACE, bleeding complications, and 30-day mortality.Findings will offer insights into the safety and clinical implications of antiplatelet therapy in high-risk patients.

Read more